These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2276222)

  • 1. Complete response to combination therapy with an LHRH agonist and flutamide in metastatic male breast cancer: a case report.
    Labrie F; Dupont A; Bélanger A; Lacourcière Y; Béland L; Cusan L; Lachance R
    Clin Invest Med; 1990 Oct; 13(5):275-8. PubMed ID: 2276222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
    Bélanger A; Labrie F; Dupont A; Brochu M; Cusan L
    Clin Invest Med; 1988 Oct; 11(5):321-6. PubMed ID: 2972431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
    Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
    Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.
    Dawson N; Figg WD; Brawley OW; Bergan R; Cooper MR; Senderowicz A; Headlee D; Steinberg SM; Sutherland M; Patronas N; Sausville E; Linehan WM; Reed E; Sartor O
    Clin Cancer Res; 1998 Jan; 4(1):37-44. PubMed ID: 9516950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
    Labrie F; Dupont A; Belanger A; Lefebvre FA; Raynaud JP
    J Pharmacol; 1983; 14 Suppl 3():117-35. PubMed ID: 6423907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.
    Labrie F; Dupont A; Belanger A; Cusan L; Lacourciere Y; Monfette G; Laberge JG; Emond JP; Fazekas AT; Raynaud JP; Husson JM
    Clin Invest Med; 1982; 5(4):267-75. PubMed ID: 6819101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete androgen blockade as treatment for advanced prostate cancer: clinical response and side-effects.
    Neri B; Bartalucci S; Pieri A; Gemelli MT; Rizzo M; Bartoletti R; Trippitelli A; Paoletti MC
    Anticancer Res; 1989; 9(1):13-6. PubMed ID: 2495750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major advantages of "early" administration of endocrine combination therapy in advanced prostate cancer.
    Labrie F; Dupont A; Cusan L; Gomez JL; Diamond P
    Clin Invest Med; 1993 Dec; 16(6):493-8. PubMed ID: 8013154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoglutethimide as second line therapy in advanced breast cancer.
    Elomaa I; Blomqvist C; Rissanen P
    Breast Cancer Res Treat; 1986; 7 Suppl():S51-4. PubMed ID: 3017481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
    Sterns EE; Bird CE; Mackie KW
    Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer.
    Chertin B; Spitz IM; Lindenberg T; Algur N; Zer T; Kuzma P; Young AJ; Catane R; Farkas A
    J Urol; 2000 Mar; 163(3):838-44. PubMed ID: 10687989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: today's therapy of choice.
    Labrie F; Dupont A; Cusan L; Giguere M; Bergeron N; Borsanyi JP; Lacourciere Y; Belanger A; Emond J; Monfette G
    J Steroid Biochem; 1988; 30(1-6):107-17. PubMed ID: 3290578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglutethimide in the treatment of metastatic breast cancer.
    Troner MB
    Cancer Res; 1982 Aug; 42(8 Suppl):3402s-3404s. PubMed ID: 7083206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of the circulating levels of glycoprotein hormone alpha-subunit after combined administration of a luteinizing hormone-releasing hormone (LHRH) agonist and flutamide in patients with cancer of the prostate.
    St-Arnaud R; Lachance R; Dupont A; Labrie F
    Clin Invest Med; 1986 Nov; 9(4):215-21. PubMed ID: 2433088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the treatment of metastatic prostatic cancer.
    Elder JS; Gibbons RP
    West J Med; 1985 Sep; 143(3):342-5. PubMed ID: 2413632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer methods of hormonal therapy for prostate cancer.
    Soloway MS
    Urology; 1984 Nov; 24(5 Suppl):30-8. PubMed ID: 6437034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology.
    Labrie F; Luu-The V; Labrie C; Simard J
    Front Neuroendocrinol; 2001 Jul; 22(3):185-212. PubMed ID: 11456468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
    Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
    Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
    Harris AL; Powles TJ; Smith IE
    Cancer Res; 1982 Aug; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.